top of page

PROFILE

CK_td04530026273_edited.jpg

하현수 연구원

하현수 증명.jpg

Fast to market advantage of rare disease therapies

Potential for accelerated approval

Rapid reimbursement access

유안타증권 리서치센터

EDUCATION

2013-2014, Chung-ang university, Master of pharmacy

2008-2012, Chung-ang university, Bachelor of pharmacy

PROFESSIONAL EXPERIENCE

2022-Present, Yuantasecurities, Equity analyst.

2019-2022, NHIS, Drug price negotiation.

2014-2017, Samjin pharmaceuticals Co., Researcher

© 2035 by NEW-CLICK. Powered and secured by Wix

bottom of page